EP Patent

EP2014284A1 — Pharmaceutical compositions and uses

Assigned to Novartis AG · Expires 2009-01-14 · 17y expired

What this patent protects

Pharmaceutical compositions, combinations and uses comprising a COX-2 inhibitor and an antihypertensive.

USPTO Abstract

Pharmaceutical compositions, combinations and uses comprising a COX-2 inhibitor and an antihypertensive.

Drugs covered by this patent

Caduet (Amlodipine Besylate) · Pfizer Inc.

Patent Metadata

Patent number: EP2014284A1
Jurisdiction: EP
Classification: —
Expires: 2009-01-14
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.